SMN1 and proximal spinal muscular atrophy: We found NGS to have 100% specificity for SMA screening when 3 loci are used to assign a sequencing to read to SMN1 or SMN2. Our feasibility study shows NGS to be a robust method for SMA screening, with all samples meeting quality metrics for DNA library preparation and sequencing and no re-testing of any sample was required.